Joseph Wolk
Director of Finance/CFO at JOHNSON & JOHNSON
Net worth: 11 M $ as of 31/03/2024
Profile
Joseph J. Wolk holds the position of Chief Financial Officer & Executive Vice President at Johnson & Johnson. Mr. Wolk is also Member of Cnbc Global Cfo Council. Mr. Wolk received an undergraduate degree from St. Joseph's University and a graduate degree from Temple University Beasley School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
JOHNSON & JOHNSON
0.00% | 15/02/2024 | 70,938 ( 0.00% ) | 11 M $ | 31/03/2024 |
KENVUE, INC.
0.00% | 23/08/2023 | 538 ( 0.00% ) | 11 545 $ | 31/03/2024 |
Joseph Wolk active positions
| Companies | Position | Start |
|---|---|---|
| JOHNSON & JOHNSON | Director of Finance/CFO | 01/07/2018 |
| KENVUE INC. | Director/Board Member | 08/05/2023 |
Cnbc Global Cfo Council
 Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Corporate Officer/Principal | - |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Wall Street Journal Cfo Network
 Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Corporate Officer/Principal | - |
| St. Joseph's University | Director/Board Member | - |
Former positions of Joseph Wolk
| Companies | Position | End |
|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Director of Finance/CFO | 01/01/2016 |
Training of Joseph Wolk
| St. Joseph's University | Undergraduate Degree |
| Temple University Beasley School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| KENVUE INC. | Consumer Non-Durables |
| Private companies | 3 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Cnbc Global Cfo Council
Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Commercial Services |
Wall Street Journal Cfo Network
Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Commercial Services |
- Stock Market
- Insiders
- Joseph Wolk
